UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2015, Volume 122, Issue 4, pp. 822 - 832
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Prospective Studies | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Wet Macular Degeneration - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Retinal Pigment Epithelium - pathology | Retinal Detachment - diagnosis | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Visual Acuity - physiology | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Tomography, Optical Coherence | Wet Macular Degeneration - diagnosis | Wet Macular Degeneration - drug therapy | Macular Edema - physiopathology | Macular Edema - diagnosis | Retinal Detachment - physiopathology | Subretinal Fluid | Aged | Blindness - etiology | Macular degeneration | Care and treatment | Drug approval | Analysis | Index Medicus
Journal Article
Annals of medicine (Helsinki), ISSN 0785-3890, 2006, Volume 38, Issue 7, pp. 450 - 471
basal laminar deposit (BLamD) | complement Factor H (CFH) | epidemiology | genetics | Age-related macular degeneration (AMD) | complement Factor B (BF) | geographic atrophy | choroidal neovascularization | inflammation | drusen | Bruch's membrane | surgery | Drusen | Choroidal neovascularization | Complement Factor B (BF) | Surgery | Geographic atrophy | Genetics | Inflammation | Basal laminar deposit (BLamD) | Epidemiology | Complement Factor H (CFH) | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Miscellaneous | Medical sciences | Age Factors | Blindness - physiopathology | Humans | Middle Aged | Risk Factors | Palliative Care | Dry Eye Syndromes - genetics | Complement Activation - immunology | Disease Progression | Complement Activation - genetics | Macular Degeneration - genetics | Macular Degeneration - therapy | Aged, 80 and over | Aging | Macular Degeneration - epidemiology | Aged | Retinal Drusen - complications | Blindness - etiology | Index Medicus | Bruch’s membrane
Journal Article
Science translational medicine, ISSN 1946-6234, 12/2016, Volume 8, Issue 368, pp. 368rv6 - 368rv6
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Genetic Therapy | Genetic Predisposition to Disease | Molecular Biology | Retinal Degeneration - genetics | Visual Prosthesis | Humans | Retina - physiopathology | Clinical Trials as Topic | Optogenetics | Stem Cells - cytology | Retinal Degeneration - physiopathology | Photoreceptor Cells | Stem Cell Transplantation | Vision, Ocular - physiology | Animals | Retinal Degeneration - therapy | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2006, Volume 355, Issue 14, pp. 1474 - 1485
Biological and medical sciences | General aspects | Medical sciences | Macular Degeneration - etiology | Smoking - adverse effects | Macular Degeneration - physiopathology | Retinal Drusen - pathology | Retinal Drusen - physiopathology | Humans | Pigment Epithelium of Eye - physiology | Disease Progression | Retina - physiology | Antioxidants - therapeutic use | Aging - physiology | Bruch Membrane - physiology | Retina - pathology | Macular Degeneration - pathology | Macular degeneration | Causes of | Drug therapy | Risk factors | Aging | Vegetables | Eyes & eyesight | Older people | Age | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of pathology, ISSN 0022-3417, 01/2014, Volume 232, Issue 2, pp. 151 - 164
retinal pigmented epithelial (RPE) cells | dry AMD | neovascular AMD (NVAMD) | choroidal neovascularization (CNV) | best corrected visual acuity (BCVA) | age‐related macular degeneration (AMD) | geographic atrophy (GA) | wet AMD | age-related macular degeneration (AMD) | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Retina - drug effects | Genetic Predisposition to Disease | Retina - metabolism | Macular Degeneration - physiopathology | Humans | Retina - physiopathology | Molecular Targeted Therapy | Drug Discovery | Macular Degeneration - drug therapy | Macular Degeneration - metabolism | Phenotype | Animals | Retina - pathology | Disease Models, Animal | Macular Degeneration - pathology | Macular degeneration | Physiological aspects | Neovascularization | Health aspects | Analysis | Blindness | Index Medicus
Journal Article